Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;16(5):442-449.
doi: 10.2174/1573399815666191024085838.

Type 2 Diabetes and its Impact on the Immune System

Afiat Berbudi  1   2 , Nofri Rahmadika  2 , Adi Imam Tjahjadi  2   3 , Rovina Ruslami  2   4
Affiliations
Review

Type 2 Diabetes and its Impact on the Immune System

Afiat Berbudi et al. Curr Diabetes Rev. 2020.

Abstract

Introduction: Type 2 Diabetes (T2D) is a major health problem worldwide. This metabolic disease is indicated by high blood glucose levels due to insufficient insulin production by the pancreas. An inflammatory response occurs as a result of the immune response to high blood glucose levels as well as the presence of inflammatory mediators produced by adipocytes and macrophages in fat tissue. This low and chronic inflammation damages the pancreatic beta cells and leads to insufficient insulin production, which results in hyperglycemia. Hyperglycemia in diabetes is thought to cause dysfunction of the immune response, which fails to control the spread of invading pathogens in diabetic subjects. Therefore, diabetic subjects are known to more susceptible to infections. The increased prevalence of T2D will increase the incidence of infectious diseases and related comorbidities.

Objective: This review provides an overview of the immunological aspect of T2D and the possible mechanisms that result in increased infections in diabetics.

Conclusion: A better understanding of how immune dysfunctions occur during hyperglycemia can lead to novel treatments and preventions for infectious diseases and T2D comorbidities, thus improving the outcome of infectious disease treatment in T2D patients.

Keywords: Type 2 diabetes; comorbidity; hyperglycemia; immune dysfunction; infection; treatment outcome..

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Molecular mechanism of insulin resistance due to inflammation [73].
Fig. (2)
Fig. (2)
Impairment in immune response mechanisms during hyperglycemia [74].
See this image and copyright information in PMC

References

    1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7): 539-53. - PubMed
    1. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. 2013.
    1. Ronacher K., Joosten S.A., van Crevel R., Dockrell H.M., Walzl G., Ottenhoff T.H.M. Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus. Immunol. Rev. 2015;264(1):121–137. doi: 10.1111/imr.12257. - DOI - PubMed
    1. Restrepo B.I. Diabetes and Tuberculosis. Microbiol. Spectr. 2016;4(6) - PMC - PubMed
    1. Vrieling F., Ronacher K., Kleynhans L., van den Akker E., Walzl G., Ottenhoff T.H.M., Joosten S.A. Patients with concurrent tuberculosis and diabetes have a pro-atherogenic plasma lipid profile. EBioMedicine. 2018;32:192–200. doi: 10.1016/j.ebiom.2018.05.011. - DOI - PMC - PubMed

MeSH terms